PATENT CLAIM ANALYSIS

Application Number: 16006308
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["549", "059000"]

Abstract:
The present invention relates to certain novel substituted thiophene compounds and the finding that they display useful efficacy in the inhibition of the p38α MAPK enzyme. This provides for use of the compounds in various treatment methodologies related to MAPK inhibition, including the treatment of inflammation.

Claim (Index 19):
The method of  claim 17  wherein the disease, disorder or condition is selected from the group consisting of arthritis, inflammatory bowel disease, asthma, psoriasis, myocardial injury, stroke, cancer, Alzheimer's disease, HIV, COPD, multiple myeloma, myelodysplastic syndrome, acute respiratory distress syndrome, coronary heart disease, acute coronary syndrome, major depressive disorder, dental pain, artherosclerosis, neuropathic pain and inflammation associated with any one or more of these diseases, disorders or conditions.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 94.0
- Lexical Diversity: 1.36111
- Patent Class: 549.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13652247', '15346443', '15048330', '12477715', '14263822']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7922236961187096
- 35 USC 102 Novelty (BERT): 0.518703900127907
- Combined Prediction Score: 0.7648717165196294
- Mean Citation Score: 299.0853620000001
- Max Citation Score: 302.8737799999999
- Similarity Product: 210.90911081533665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test